India L-Carnosine Market Size, Share & Trends Analysis Report by Application (Autism, Diabetes, Skin Support, Cardiovascular Support, Joint Support, and Others) and Forecast, 2020-2026.
India L-carnosine market is estimated to grow at a CAGR of over 5% during the forecast period. The rising aging population is one of the major factors driving the market growth. As per the World Bank, in 2018, there were more than 83 million of the elderly population (65 and above) that is over 6.1% of the total population. As older people are more prone to diseases such as diabetes, joint pain among others, the demand for l-carnosine supplements is expected to grow significantly in the country. For instance, as per the National Health Portal (NHP), Osteoarthritis (OA) is the second most common disease in India.
India L-carnosine market is segmented on the basis of application and geography. Based on the application, the market is segmented into autism, diabetes support, skin support, CVD support, joint support, and others. Others segment include digestion support, Parkinson’s disease, and Alzheimer’s disease. In 2019, the skin support segment is projected to contribute a significant share to the global market.
Companies operating in the market include Panvo Organics Pvt Ltd., Manus Aktteva Biopharma LLP, NOW Foods, LLC, and Puneet Laboratories Pvt. Ltd. Under the specialty products division, Puneet Laboratories Pvt Ltd. offers L-Carnosine Nature’s Cell-Life Protector which is intended for the prevention of neurodegeneration. L-Carnosine is the brain that helps suppress oxidative stress, copper-zinc toxicity, lipid peroxidation, sustain the long lives of neurons, pathological protein-sugar interactions, decrease the risk of neurodegeneration, prevent oxidation of lipids in the membranes of brain cells, and slowing down the initiated process in diabetes. L-Carnosine can attenuate cellular oxidative stress and can restrict the intracellular formation of reactive nitrogen species (RNS) and reactive oxygen species (ROS), with its unique combination of antiglycation and antioxidant properties.
Research Methodology:
The market study of the India L-carnosine market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include:
The report is intended for the pharmaceutical companies, healthcare industry, research institutes, academic institutes, dietary supplement companies, investing companies, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation:
The Report Covers:
India L-carnosine market is estimated to grow at a CAGR of over 5% during the forecast period. The rising aging population is one of the major factors driving the market growth. As per the World Bank, in 2018, there were more than 83 million of the elderly population (65 and above) that is over 6.1% of the total population. As older people are more prone to diseases such as diabetes, joint pain among others, the demand for l-carnosine supplements is expected to grow significantly in the country. For instance, as per the National Health Portal (NHP), Osteoarthritis (OA) is the second most common disease in India.
India L-carnosine market is segmented on the basis of application and geography. Based on the application, the market is segmented into autism, diabetes support, skin support, CVD support, joint support, and others. Others segment include digestion support, Parkinson’s disease, and Alzheimer’s disease. In 2019, the skin support segment is projected to contribute a significant share to the global market.
Companies operating in the market include Panvo Organics Pvt Ltd., Manus Aktteva Biopharma LLP, NOW Foods, LLC, and Puneet Laboratories Pvt. Ltd. Under the specialty products division, Puneet Laboratories Pvt Ltd. offers L-Carnosine Nature’s Cell-Life Protector which is intended for the prevention of neurodegeneration. L-Carnosine is the brain that helps suppress oxidative stress, copper-zinc toxicity, lipid peroxidation, sustain the long lives of neurons, pathological protein-sugar interactions, decrease the risk of neurodegeneration, prevent oxidation of lipids in the membranes of brain cells, and slowing down the initiated process in diabetes. L-Carnosine can attenuate cellular oxidative stress and can restrict the intracellular formation of reactive nitrogen species (RNS) and reactive oxygen species (ROS), with its unique combination of antiglycation and antioxidant properties.
Research Methodology:
The market study of the India L-carnosine market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include:
- Financial reports of companies involved in the market
- Authentic public databases
- Whitepapers, research-papers, and news blogs
- Company websites and their product catalog
The report is intended for the pharmaceutical companies, healthcare industry, research institutes, academic institutes, dietary supplement companies, investing companies, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation:
- India L-carnosine Market Research and Analysis by Application
The Report Covers:
- Comprehensive research methodology of the India L-carnosine market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the India L-carnosine market.
- Insights about market determinants which are stimulating the India L-carnosine market.
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- Alpspure Lifesciences Pvt Ltd.
- Angle Bio Pharma
- Bachem AG
- Brio Bliss Life Science Pvt. Ltd.
- Kirkman Group, Inc.
- Manus Aktteva Biopharma LLP
- NOW Foods, LLC
- Panvo Organics Pvt Ltd.
- Puneet Laboratories Pvt. Ltd.
- Zeon Biotech